Cargando…
Deubiquitinylase USP47 Promotes RelA Phosphorylation and Survival in Gastric Cancer Cells
Every year, gastric cancer causes around 819,000 deaths worldwide. The incidence of gastric cancer in the western world is slowly declining, but the prognosis is unpromising. In Germany, the 5-year-survival rate is around 32%, and the average life span after diagnosis is 6 to 9 months. Therapy of ga...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027160/ https://www.ncbi.nlm.nih.gov/pubmed/29786670 http://dx.doi.org/10.3390/biomedicines6020062 |
_version_ | 1783336547514318848 |
---|---|
author | Naghavi, Lara Schwalbe, Martin Ghanem, Ahmed Naumann, Michael |
author_facet | Naghavi, Lara Schwalbe, Martin Ghanem, Ahmed Naumann, Michael |
author_sort | Naghavi, Lara |
collection | PubMed |
description | Every year, gastric cancer causes around 819,000 deaths worldwide. The incidence of gastric cancer in the western world is slowly declining, but the prognosis is unpromising. In Germany, the 5-year-survival rate is around 32%, and the average life span after diagnosis is 6 to 9 months. Therapy of gastric cancer patients comprises a gastrectomy and perioperative or adjuvant chemotherapy. However, resistance of gastric cancer cells to these agents is widespread; thus, improved chemotherapeutic approaches are required. Nuclear factor kappa B (NF-κB) transcription factors are associated with anti-apoptosis, carcinogenesis, and chemoresistance, and thus, constitute attractive targets for therapeutic intervention. In immunoblots, we show that ubiquitin specific protease 47 (USP47) promotes β-transducin repeat-containing protein (βTrCP) stability and phosphorylation of RelA. Furthermore, after knockdown of USP47 by RNA interference, we analyzed in gastric cancer cell lines metabolic activity/viability in an MTT assay, and apoptotic cell death by Annexin V staining and poly(ADP-Ribose) polymerase (PARP)-1, caspase 3, and caspase 8 cleavage, respectively. We found that USP47 contributes to cell viability and chemoresistance in NCI-N87 gastric carcinoma cells treated with etoposide and camptothecin. Inhibition of USP47 might be a suitable strategy to downregulate NF-κB activity, and to overcome chemoresistance in gastric cancer. |
format | Online Article Text |
id | pubmed-6027160 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-60271602018-07-13 Deubiquitinylase USP47 Promotes RelA Phosphorylation and Survival in Gastric Cancer Cells Naghavi, Lara Schwalbe, Martin Ghanem, Ahmed Naumann, Michael Biomedicines Article Every year, gastric cancer causes around 819,000 deaths worldwide. The incidence of gastric cancer in the western world is slowly declining, but the prognosis is unpromising. In Germany, the 5-year-survival rate is around 32%, and the average life span after diagnosis is 6 to 9 months. Therapy of gastric cancer patients comprises a gastrectomy and perioperative or adjuvant chemotherapy. However, resistance of gastric cancer cells to these agents is widespread; thus, improved chemotherapeutic approaches are required. Nuclear factor kappa B (NF-κB) transcription factors are associated with anti-apoptosis, carcinogenesis, and chemoresistance, and thus, constitute attractive targets for therapeutic intervention. In immunoblots, we show that ubiquitin specific protease 47 (USP47) promotes β-transducin repeat-containing protein (βTrCP) stability and phosphorylation of RelA. Furthermore, after knockdown of USP47 by RNA interference, we analyzed in gastric cancer cell lines metabolic activity/viability in an MTT assay, and apoptotic cell death by Annexin V staining and poly(ADP-Ribose) polymerase (PARP)-1, caspase 3, and caspase 8 cleavage, respectively. We found that USP47 contributes to cell viability and chemoresistance in NCI-N87 gastric carcinoma cells treated with etoposide and camptothecin. Inhibition of USP47 might be a suitable strategy to downregulate NF-κB activity, and to overcome chemoresistance in gastric cancer. MDPI 2018-05-22 /pmc/articles/PMC6027160/ /pubmed/29786670 http://dx.doi.org/10.3390/biomedicines6020062 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Naghavi, Lara Schwalbe, Martin Ghanem, Ahmed Naumann, Michael Deubiquitinylase USP47 Promotes RelA Phosphorylation and Survival in Gastric Cancer Cells |
title | Deubiquitinylase USP47 Promotes RelA Phosphorylation and Survival in Gastric Cancer Cells |
title_full | Deubiquitinylase USP47 Promotes RelA Phosphorylation and Survival in Gastric Cancer Cells |
title_fullStr | Deubiquitinylase USP47 Promotes RelA Phosphorylation and Survival in Gastric Cancer Cells |
title_full_unstemmed | Deubiquitinylase USP47 Promotes RelA Phosphorylation and Survival in Gastric Cancer Cells |
title_short | Deubiquitinylase USP47 Promotes RelA Phosphorylation and Survival in Gastric Cancer Cells |
title_sort | deubiquitinylase usp47 promotes rela phosphorylation and survival in gastric cancer cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027160/ https://www.ncbi.nlm.nih.gov/pubmed/29786670 http://dx.doi.org/10.3390/biomedicines6020062 |
work_keys_str_mv | AT naghavilara deubiquitinylaseusp47promotesrelaphosphorylationandsurvivalingastriccancercells AT schwalbemartin deubiquitinylaseusp47promotesrelaphosphorylationandsurvivalingastriccancercells AT ghanemahmed deubiquitinylaseusp47promotesrelaphosphorylationandsurvivalingastriccancercells AT naumannmichael deubiquitinylaseusp47promotesrelaphosphorylationandsurvivalingastriccancercells |